Xiaoyang Wu builds biomaterials and genome-engineering platforms with patents in lactate-responsive oncology systems and replicon-mediated gene therapy. Programs include mucosal‑adhesive hydrogels, scar‑modulating wound dressings, nanoparticle carriers, and skin graft–enabled therapeutic protein delivery for metabolic and addiction indications.